Dr Michael Gantier
ARC Future
Fellow
Centre for
Innate Immunity and Infectious Diseases
The
central aim of Dr Michael Gantier’s research is to define how
nucleic acids modulate immune responses, in both
homeostatic conditions and following infection. After joining
Professor Bryan Williams’ laboratory in 2006, Dr
Gantier
set out to investigate how endogenous and foreign nucleic
acids controlled innate immune responses. Building
on technical expertise on small RNAs acquired during his
PhD (University College Dublin, Ireland), he
established
this research theme in the Williams laboratory, and more
broadly in Australia.
In 2015,
following the award of an ARC Future Fellowship and
several NHMRC project grants, he was promoted to lead his
own research group in the Hudson Institute of Medical
Research. The group’s research has important implications
for our basic understanding of inflammation and the
translational use of nucleic acids therapeutics in the
clinic.
Amongst
his scientific achievements are publications in the highest-ranking
science and medical research journals, including
Nature Immunology, Cell Host Microbe, Nucleic Acids
Research, PNAS, Journal of Virology, Journal of Immunology,
among others.
No comments:
Post a Comment